ArticleDiscover oncology2025
Intratumor heterogeneity related signature for clinical outcome and immunotherapy advantages in lung adenocarcinoma.
Yanhua Zuo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it